Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib

被引:226
|
作者
Emsley, J
Cruz, M
Handin, R
Liddington, R [1 ]
机构
[1] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
[2] Brigham & Womens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.273.17.10396
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
von Willebrand Factor (vWF) is a multimeric protein that mediates platelet adhesion to exposed subendothelium at sites of vascular injury under conditions of high flow/shear. The Al domain of vWF (vWF-A1) forms the principal binding site for platelet glycoprotein Ib (GpIb), an interaction that is tightly regulated. We report here the crystal structure of the vWF-A1 domain at 2.3-Angstrom resolution. As expected, the overall fold is similar to that of the vWF-A3 and integrin I domains. However, the structure also contains N- and C-terminal arms that wrap across the lower surface of the domain. Unlike the integrin I domains, vWF-A1 does not contain a metal ion-dependent adhesion site motif. Analysis of the available mutagenesis data suggests that the activator botrocetin binds to the right-hand face of the domain containing helices alpha 5 and alpha 6. Possible binding sites for GpIb are the front and upper surfaces of the domain. Natural mutations that lead to constitutive GpIb binding (von Willebrand type IIb disease) cluster in a different site, at the interface between the lower surface and the terminal arms, suggesting that they disrupt a regulatory region rather than forming part of the primary GpIb binding site. A possible pathway for propagating structural changes from the regulatory region to the ligand-binding surface is discussed.
引用
收藏
页码:10396 / 10401
页数:6
相关论文
共 50 条
  • [41] The glycoprotein Ibα-von Willebrand factor interaction induces platelet apoptosis
    Li, S.
    Wang, Z.
    Liao, Y.
    Zhang, W.
    Shi, Q.
    Yan, R.
    Ruan, C.
    Dai, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (02) : 341 - 350
  • [42] Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibα
    Martin, C.
    Morales, L. D.
    Cruz, M. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1363 - 1370
  • [43] ROLE OF THE GLYCOPROTEIN IB-BINDING A1 REPEAT AND THE RGD SEQUENCE IN PLATELET-ADHESION TO HUMAN RECOMBINANT VON-WILLEBRAND-FACTOR
    LANKHOF, H
    WU, YP
    VINK, T
    SCHIPHORST, ME
    ZERWES, HG
    DEGROOT, PG
    SIXMA, JJ
    BLOOD, 1995, 86 (03) : 1035 - 1042
  • [44] The A/T1381 polymorphism in the Al-domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein Ibα
    Szanto, Timea
    Schlammadinger, Agota
    Staelens, Stephanie
    De Meyer, Simon F.
    Freson, Kathleen
    Pareyn, Inge
    Vauterin, Stephan
    Harsfalvi, Jolan
    Deckmyn, Hans
    Vanhoorelbeke, Karen
    THROMBOSIS AND HAEMOSTASIS, 2007, 98 (01) : 178 - 185
  • [45] Crystal Structure of Von Willebrand Factor (VWF) A1 Domain in Complex with Aptamer ARC1172, An Inhibitor of VWF-Platelet Binding
    Huang, Ren-Huai
    Fremont, David
    Tuley, Elodee A.
    Diener, John L.
    Schaub, Robert G.
    Sadler, J. Evan
    BLOOD, 2008, 112 (11) : 101 - 102
  • [46] Glycoprotein Ibα forms catch bonds with von Willebrand factor A1 domain but not with mutant A1 domains exhibiting properties of type 2B von Willebrand disease
    Wu, Tao
    Yago, Tadayuki
    Yang, Jun
    Miner, Jonathan
    Coburn, Leslie
    Lopez, Jose A.
    Cruz, Miguel A.
    McIntire, Larry V.
    McEver, Rodger P.
    Zhu, Cheng
    BLOOD, 2007, 110 (11) : 93A - 93A
  • [47] Inhibition of cyclic flow variations by von Willebrand factor-glycoprotein Ib binding domain
    Tousoulis, D
    Tentolouris, C
    Bosinakou, E
    Apostolopoulos, T
    Toutouzas, P
    CIRCULATION, 1996, 93 (06) : 1255 - 1255
  • [48] ALANINE SCANNING MUTAGENESIS OF THE A1 DOMAIN OF HUMAN VON-WILLEBRAND-FACTOR IDENTIFIES AMINO-ACID-RESIDUES ESSENTIAL FOR NORMAL BINDING TO PLATELET GLYCOPROTEIN-IB
    MATSUSHITA, T
    SADLER, JE
    BLOOD, 1994, 84 (10) : A387 - A387
  • [49] Two anti-von Willebrand factor antibodies distinguish two regions of the A1 domain involved in binding to the platelet glycoprotein Ib-IX-V complex.
    Facey, DA
    Hertzberg, MS
    Koutts, J
    Favaloro, EJ
    Andrews, RA
    DeLuca, M
    Berndt, MC
    BLOOD, 1996, 88 (10) : 102 - 102
  • [50] Liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ib alpha enhance ristocetin-induced platelet aggregation
    Kitaguchi, T
    Murata, R
    Iijima, K
    Okada, M
    Amatsuji, Y
    Kamide, K
    Imagawa, T
    Matsuda, H
    Ruggeri, ZM
    Ikeda, Y
    THROMBOSIS AND HAEMOSTASIS, 1997, : OC735 - OC735